Paraneoplastic Optic Neuropathy Associated With Purkinje Cell Antibody-2 in a Patient With Small Cell Lung Cancer

J Neuroophthalmol. 2017 Mar;37(1):53-55. doi: 10.1097/WNO.0000000000000458.

Abstract

Paraneoplastic optic neuropathy (PON) is a rare cause of vision loss usually associated with small cell lung cancer. Patients with this condition usually test positive for anti-collapsin response mediating protein-5 (CRMP-5). We describe a case of a 57-year-old woman with bilateral vision loss with the characteristic features of CRMP-5 PON including bilateral optic disc edema and vitreous cells. However, she was negative for anti-CRMP-5 including a negative Western blot on two occasions, but positive for Purkinje Cell Antibody (PCA)-2. Although paraneoplastic antibodies are more predictive of an underlying cancer than a specific syndrome, previously PON has not been associated with PCA-2. Based on this observation, we recommend that the workup should include PCA-2 antibodies in patients who present with bilateral optic neuropathy and vitreous cells.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Humans
  • Lung Neoplasms / complications*
  • Lung Neoplasms / diagnosis
  • Middle Aged
  • Ophthalmoscopy
  • Optic Nerve Diseases / diagnosis
  • Optic Nerve Diseases / etiology*
  • Paraneoplastic Syndromes, Ocular*
  • Small Cell Lung Carcinoma / complications*
  • Small Cell Lung Carcinoma / diagnosis